Number of the records: 1
proteín inhibujúci komplement C1
SYS d050718 LBL 00000nz--a2200000o--4500 005 20250606214914.6 008 050630|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D09.400.430.780 065 $a D12.644.861.140.500 065 $a D12.776.124.486.274.920.250.500 065 $a D12.776.395.320 065 $a D12.776.872.140.500 066 $a 01 $c 03 150 $a proteín inhibujúci komplement C1 $x AD $x AE $x AG $x AN $x BI $x CF $x CH $x CL $x CS $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a C1 inhibítor $2 slo 550 $7 sllk_us_auth*d051056 $Y Complement Inactivating Agents $w P $a inhibítory aktivácie komplementu 550 $7 sllk_us_auth*d056829 $Y Hereditary Angioedema Types I and II $w b $a angioedémy dedičné, typ I a II 665 $a 2006; for C1 ESTERASE INHIBITOR use COMPLEMENT C1 INACTIVATOR PROTEINS 1970-2005 $2 eng 665 $a Complement C1 Inactivator Proteins (1970-2005) $2 eng 680 9-
$i An endogenous 105-kDa plasma glycoprotein produced primarily by the LIVER and MONOCYTES. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from HEREDITARY ANGIOEDEMA TYPES I AND II. $2 eng 680 $a do not confuse with COMPLEMENT C1 INACTIVATOR PROTEINS $2 eng 750 -2
$a Complement C1 Inhibitor Protein $2 eng 980 $x M
Number of the records: 1